1s9g
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1S9G is a 2 chains structure | + | 1S9G is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S9G OCA]. |
==Reference== | ==Reference== | ||
| Line 27: | Line 27: | ||
[[Category: RNA-directed DNA polymerase]] | [[Category: RNA-directed DNA polymerase]] | ||
[[Category: Arnold, E.]] | [[Category: Arnold, E.]] | ||
| + | [[Category: Clark, A D.]] | ||
[[Category: Das, K.]] | [[Category: Das, K.]] | ||
[[Category: Decorte, B.]] | [[Category: Decorte, B.]] | ||
[[Category: Hughes, S H.]] | [[Category: Hughes, S H.]] | ||
[[Category: Janssen, P A.]] | [[Category: Janssen, P A.]] | ||
| - | [[Category: Jr., A D.Clark.]] | ||
[[Category: Kukla, M J.]] | [[Category: Kukla, M J.]] | ||
[[Category: Lewi, P J.]] | [[Category: Lewi, P J.]] | ||
| Line 42: | Line 42: | ||
[[Category: Reverse transcriptase]] | [[Category: Reverse transcriptase]] | ||
[[Category: Rt]] | [[Category: Rt]] | ||
| + | [[Category: Transferase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Oct 13 10:14:38 2010'' |
Revision as of 07:04, 13 October 2010
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
Template:ABSTRACT PUBMED 15115397
About this Structure
1S9G is a 2 chains structure with sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
- Das K, Clark AD Jr, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Bethune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, Arnold E. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J Med Chem. 2004 May 6;47(10):2550-60. PMID:15115397 doi:http://dx.doi.org/10.1021/jm030558s
Page seeded by OCA on Wed Oct 13 10:14:38 2010
Categories: Human immunodeficiency virus 1 | RNA-directed DNA polymerase | Arnold, E. | Clark, A D. | Das, K. | Decorte, B. | Hughes, S H. | Janssen, P A. | Kukla, M J. | Lewi, P J. | Ludovici, D W. | Aid | Drug design | Hiv | Protein-inhibitor complex | R120393 | Reverse transcriptase | Rt | Transferase
